Articles Referencing MYL
After Hours Most Active for May 20, 2013 : QQQ, SID, GGB, PBR, OZM, MSFT, APO, AAPL, BAC, RFMD, MYL, DEPO
5/20/2013, 4:43 pm from NASDAQ.com News in News Headlines, After Hours Most Active
The NASDAQ 100
After Hours Indicator is up .45 to 3,021.42. The total After
hours volume is currently 19,594,794 shares traded.
The following are the
most active stocks for the after hours... Read >>
Valeant Misses Earnings and Revenue Estimate in 1Q (Revised) - Analyst Blog
5/7/2013, 9:27 am from Zacks.com in Investing, Business, Earnings, Stocks
Valeant Pharmaceuticals' ( VRX ) first quarter
2013 earnings of $1.27 (excluding special items but including
stock-based compensation expense) were short of the Zacks Consensus
Estimate... Read >>
Valeant Beats Earnings, Misses Revs - Analyst Blog
5/3/2013, 1:31 pm from Zacks.com in Investing, Business, Earnings, Stocks
Valeant Pharmaceuticals' ( VRX ) first quarter
2013 earnings of $1.27 (excluding special items but including
stock-based compensation expense) were short of the Zacks Consensus
Estimate by... Read >>
Mylan Reports in line Earnings - Analyst Blog
5/3/2013, 8:31 am from Zacks.com in Investing, Business, Earnings, Stocks
Mylan, Inc. 's ( MYL ) first quarter
2013 earnings (excluding special items) of 62 cents per share were
in line with the Zacks Consensus Estimate. Earnings increased 19%
from the year-ago... Read >>
After-Hours Earnings Report for May 2, 2013 : GILD, AIG, CNQ, LNKD, MYL, WFT, FLR, XL, TDC, MHK, MCHP, CPT
5/2/2013, 2:00 pm from NASDAQ.com News in News Headlines, Earnings
The following companies are expected to report earnings after
hours on 05/02/2013. Visit our Earnings
Calendar for a full list of expected earnings releases. Gilead Sciences, Inc. ( GILD )... Read >>
Orphan Drug Status for Teva/Xenon Drug - Analyst Blog
4/26/2013, 4:22 pm from Zacks.com in Investing, Business, Stocks
The US Food and Drug Administration (FDA) recently granted
orphan drug designation to Teva Pharmaceutical Industries
Ltd ( TEVA
) and Xenon Pharmaceuticals Inc. for their pain... Read >>
After Hours Most Active for Apr 25, 2013 : ORI, PLD, MO, MSFT, DAL, JCP, GM, NTAP, MU, MYL, QQQ, AMZN
4/25/2013, 4:44 pm from NASDAQ.com News in News Headlines, After Hours Most Active
The NASDAQ 100
After Hours Indicator is down -1.04 to 2,847.62. The total
After hours volume is currently 34,030,675 shares traded.
The following are the
most active stocks for the after... Read >>
Favorable Court Ruling for Actavis - Analyst Blog
4/19/2013, 6:13 pm from Zacks.com in Investing, Business, Stocks
Actavis, Inc. ( ACT ) recently
re-launched Vestura (3 mg drospirenone and 0.02 mg ethinyl
estradiol), the company's generic version of
Bayer's ( BAYRY ) oral
contraceptive, Yaz. Actavis... Read >>
Data on Teva's Milprosa - Analyst Blog
4/18/2013, 7:13 pm from Zacks.com in Investing, Business, Stocks
Teva Pharmaceuticals ( TEVA ) recently
announced new data from a phase III study on Milprosa
(progesterone) vaginal ring which is being developed for luteal
phase support in women... Read >>
Still Neutral on Mylan - Analyst Blog
4/15/2013, 6:20 pm from Zacks.com in Investing, Business, Stocks
We are maintaining our Neutral recommendation on Mylan
Inc. ( MYL
) with a target price of $30.00. Why the Reiteration ?
Mylan performed well in the fourth quarter of 2012. Mylan's... Read >>
Good News for Warner Chilcott - Analyst Blog
4/15/2013, 5:50 pm from Zacks.com in Investing, Business, Stocks
Warner Chilcott plc ( WCRX ) recently
received encouraging news from the US Food and Drug Administration
(FDA) when the regulatory agency approved the company's acne drug
Doryx at 200 mg... Read >>
Actavis Settles with Valeant - Analyst Blog
4/11/2013, 1:09 pm from Zacks.com in Investing, Business, Stocks
Actavis, Inc. ( ACT ), and
Valeant Pharmaceuticals International, Inc.'s ( VRX ) Medicis
Pharmaceutical Corporation recently entered into settlement
agreements regarding a couple... Read >>
TRO on Actavis Sale of Generic Pulmicort Respules - Analyst Blog
4/10/2013, 10:50 am from Zacks.com in Investing, Business, Stocks
Actavis, Inc. ( ACT ) recently said
that the US District Court for the District of New Jersey has
granted AstraZeneca 's ( AZN ) motion to issue a
temporary restraining order (TRO)... Read >>
Valeant Inks Deal with Actavis - Analyst Blog
4/8/2013, 5:07 pm from Zacks.com in Investing, Business, Stocks
Valeant Pharmaceuticals ( VRX ) recently entered
into an agreement with Actavis Inc. ( ACT ). As per the
agreement, effective immediately, Actavis will exclusively market
and distribute... Read >>
Setback for Valeant Pharma - Analyst Blog
4/5/2013, 1:09 pm from Zacks.com in Investing, Business, Stocks
Valeant Pharmaceuticals International, Inc. (
VRX ) recently
stated that it anticipates its 2013 guidance to decline following
the approval of a generic version of its... Read >>